Everybody 12 /Conferences 0 /News 0 /Opinions 0 /Opportunities 3 /Presentations 8 /Uncategorized 1 /Webinars 0
Get 10% off Sachs Associates' 9th Annual Immuno-Oncology Innovation Forum #Sachs_IOIF, June 2, at the Waldorf Astoria Chicago. The programme is designed to discuss key industry trends and milestones on the eve of the ASCO meeting. The event brings together leaders from cancer research institutes, patient advocacy groups, pharma and biotech, and Wall Street, to facilitate partnering, funding and investment. We anticipate around 250 delegates and 25+ company presentations by established and emerging companies with part of the audience participating virtually. We've secured a 10% discount on registration for members of our network. (Just say you're with FreeMind when you register.) There's also a limited number of complimentary passes for qualified institutional (buy/sell-side), private equity, and venture investors.

Sachs Associates’ 9th Immuno-Oncology Innovation Forum

March 21, 2023/by Ayal Ronen
ARPA-H announces its first funding opportunity

ARPA-H Announces 1st Funding Opportunities

March 19, 2023/by Ayal Ronen
Find out about the 2023 CDMRP non-dilutive funding awards

CDMRP Funding Opportunities 2023: Detailed Information

February 14, 2023/by Ayal Ronen
Get information about the $370 million dollars of non-dilutive funding available through the 2023 Peer Review Medical Research Program, part of the Congressional Directed Research Program.

PRMRP Funding Opportunities 2023

February 9, 2023/by Ayal Ronen
National Institute of Neurological Disorders and Stroke (NINDS) Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Charles L. Cywin

NINDS at NDFS 2023, with Dr. Charles L. Cywin

February 2, 2023/by Ayal Ronen
National Institute on Aging (NIA) Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Armineh Ghazarian

NIA at NDFS 2023, with Dr. Armineh Ghazarian

February 2, 2023/by Ayal Ronen
Biomedical Advanced Research and Development Authority (BARDA) Presentation, at the 18th Non-Dilutive Funding Summit, by Director of Medical Countermeasures, Dr. Robert Johnson

BARDA at NDFS 2023, with Dr. Robert Johnson

February 2, 2023/by Ayal Ronen
National Heart, Lung, and Blood Institute Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Kathleen Rousche

NHLBI at NDFS 2023, with Dr. Kathleen Rousche

February 2, 2023/by Ayal Ronen
The Advanced Research Projects Agency for Health (ARPA-H) Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Inaugural Director Dr. Renee Wegrzyn

ARPA-H at NDFS 2023, with Inaugural Director Dr. Renee Wegrzyn

February 2, 2023/by Ayal Ronen
Small Business Education and Entrepreneurial Development (SEED), in the Office of the Director, at NIH, presented at the 18th Non-Dilutive Funding Summit, 2023. Director Dr. Matthew McMahon

SEED at NDFS 2023, with Director Dr. Matthew McMahon

February 2, 2023/by Ayal Ronen
California Institute for Regenerative Medicine Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Shyam Patel

CIRM at NDFS 2023, with Dr. Patel

February 2, 2023/by Ayal Ronen
National Institute of Allergy and Infectious Disease Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Natalia Kruchinin

NIAID at NDFS 2023, with Dr. Kruchinin

February 2, 2023/by Ayal Ronen

Recent Posts

Categories

Followon TwitterSubscribeto RSS Feed

Reach out to us with your non-dilutive funding requirements

Skip to content